SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-011887
Filing Date
2016-04-04
Accepted
2016-04-04 10:42:46
Documents
4
Period of Report
2016-05-24
Effectiveness Date
2016-04-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228134zdef14a.htm DEF 14A 322164
2 G21372DEI001.GIF g21372dei001.gif GRAPHIC 79748
3 G21372DEI002.GIF g21372dei002.gif GRAPHIC 109306
4 G214821.JPG g214821.jpg GRAPHIC 19121
  Complete submission text file 0001047469-16-011887.txt   609994
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36351 | Film No.: 161549299
SIC: 2834 Pharmaceutical Preparations